12743 related articles for article (PubMed ID: 12234027)
1. Nm23 gene product expression in invasive breast cancer--immunohistochemical analysis and clinicopathological correlation.
Belev B; Alerić I; Vrbanec D; Petrovecki M; Unusic J; Jakić-Razumović J
Acta Oncol; 2002; 41(4):355-61. PubMed ID: 12234027
[TBL] [Abstract][Full Text] [Related]
2. Lack of prognostic significance of nm23 expression in human primary breast cancer.
Göhring UJ; Eustermann I; Becker M; Neuhaus W; Rein DT; Schöndorf T
Oncol Rep; 2002; 9(6):1205-8. PubMed ID: 12375020
[TBL] [Abstract][Full Text] [Related]
3. Nm-23, c-erbB-2, and progesterone receptor expression in invasive breast cancer: correlation with clinicopathologic parameters.
Nakopoulou LL; Tsitsimelis D; Lazaris AC; Tzonou A; Gakiopoulou H; Dicoglou CC; Davaris PS
Cancer Detect Prev; 1999; 23(4):297-308. PubMed ID: 10403901
[TBL] [Abstract][Full Text] [Related]
4. Expression of NM23 and tenascin in invasive ductal carcinomas of the breast.
Kaya H; Hücümenoğlu S; Bozkurt SU; Ekicioğlu G; Kotiloğlu E
Eur J Gynaecol Oncol; 2002; 23(3):261-3. PubMed ID: 12094967
[TBL] [Abstract][Full Text] [Related]
5. C-erbB-2, p53, and nm23 gene product expression in breast cancer in young women: immunohistochemical analysis and clinicopathologic correlation.
Bertheau P; Steinberg SM; Merino MJ
Hum Pathol; 1998 Apr; 29(4):323-9. PubMed ID: 9563780
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneous expression of nm23 gene product as a predictor of lymph nodal status in human breast cancer.
Yoshida H; Kijima H; Terasaki Y; Suto A; Takeshita T; Omiya H; Shimojima K; Shimbori M; Sato T; Sato S; Onoda N; Yamazaki H; Tamaoki N; Ueyama Y; Nakamura M
Int J Oncol; 1998 Dec; 13(6):1141-6. PubMed ID: 9824622
[TBL] [Abstract][Full Text] [Related]
7. Decreased nm23 expression, but not Ki-67 labeling index, is significantly correlated with lymph node metastasis of breast invasive ductal carcinoma.
Terasaki-Fukuzawa Y; Kijima H; Suto A; Takeshita T; Iezumi K; Sato S; Yoshida H; Sato T; Shimbori M; Shiina Y
Int J Mol Med; 2002 Jan; 9(1):25-9. PubMed ID: 11744991
[TBL] [Abstract][Full Text] [Related]
8. Expression of metastasis-associated genes h-mts1 (S100A4) and nm23 in carcinoma of breast is related to disease progression.
Albertazzi E; Cajone F; Leone BE; Naguib RN; Lakshmi MS; Sherbet GV
DNA Cell Biol; 1998 Apr; 17(4):335-42. PubMed ID: 9570150
[TBL] [Abstract][Full Text] [Related]
9. nm23 protein expression in fine-needle aspirates from breast carcinoma: inverse correlation with cytologic grading, lymph node status, and ploidy.
Sauer T; Furu I; Beraki K; Jebsen PW; Ormerod E; Naess O
Cancer; 1998 Apr; 84(2):109-14. PubMed ID: 9570214
[TBL] [Abstract][Full Text] [Related]
10. Nm23 expression in breast ductal carcinomas: a ten year follow-up study in a uniform group of node-negative breast cancer patients.
Kapranos N; Karaiossifidi H; Kouri E; Vasilaros S
Anticancer Res; 1996; 16(6C):3987-90. PubMed ID: 9042324
[TBL] [Abstract][Full Text] [Related]
11. nm23 expression in human breast cancer: correlation with cell proliferation (S-phase) as observed with a double-labeling immunocytochemical-autoradiographic technique.
Simone G; Mangia A; Petroni S; Trotti I; Paradiso A; Marzullo F; De Lena M; Leone A
Int J Oncol; 1998 May; 12(5):1055-9. PubMed ID: 9538128
[TBL] [Abstract][Full Text] [Related]
12. Potential markers predicting distant metastasis in axillary node-negative breast carcinoma.
Niu Y; Fu X; Lv A; Fan Y; Wang Y
Int J Cancer; 2002 Apr; 98(5):754-60. PubMed ID: 11920647
[TBL] [Abstract][Full Text] [Related]
13. Expression of nm23-H1 in colorectal cancer: no association with metastases, histological stage, or survival.
Tabuchi Y; Nakamura T; Kuniyasu T; Ohno M; Nakae S
Surg Today; 1999; 29(2):116-20. PubMed ID: 10030735
[TBL] [Abstract][Full Text] [Related]
14. nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients.
Russell RL; Geisinger KR; Mehta RR; White WL; Shelton B; Kute TE
Cancer; 1997 Mar; 79(6):1158-65. PubMed ID: 9070493
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of Nm23/NDPK expression in breast carcinoma, assessed on 10-year follow-up by automated and quantitative immunocytochemical assays.
Charpin C; Garcia S; Bonnier P; Martini F; Andrac L; Horschowski N; Lavaut MN; Allasia C
J Pathol; 1998 Apr; 184(4):401-7. PubMed ID: 9664906
[TBL] [Abstract][Full Text] [Related]
16. Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer.
Tokunaga Y; Urano T; Furukawa K; Kondo H; Kanematsu T; Shiku H
Int J Cancer; 1993 Aug; 55(1):66-71. PubMed ID: 8102131
[TBL] [Abstract][Full Text] [Related]
17. Loss of nm23 expression predicts distal metastases and poorer survival for breast cancer.
Mao H; Liu H; Fu X; Fang Z; Abrams J; Worsham MJ
Int J Oncol; 2001 Mar; 18(3):587-91. PubMed ID: 11179491
[TBL] [Abstract][Full Text] [Related]
18. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.
Heimann R; Lan F; McBride R; Hellman S
Cancer Res; 2000 Jan; 60(2):298-304. PubMed ID: 10667580
[TBL] [Abstract][Full Text] [Related]
19. Automated and quantitative immunocytochemical assays of Nm23/NDPK protein in breast carcinomas.
Charpin C; Bouvier C; Garcia S; Martini F; Andrac L; Lavaut MN; Allasia C
Int J Cancer; 1997 Aug; 74(4):416-20. PubMed ID: 9291431
[TBL] [Abstract][Full Text] [Related]
20. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis.
Yan J; Liu XL; Han LZ; Xiao G; Li NL; Deng YN; Yin LC; Ling LJ; Yu XY; Tan CL; Huang XP; Liu LX
Asian Pac J Cancer Prev; 2015; 16(2):823-9. PubMed ID: 25684532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
